Terminated PHASE4 INTERVENTIONAL 2-arm NCT01865240

Renal Denervation for Resistant Hypertension (RDNP-2012-01)

Sponsor: Baker Heart and Diabetes Institute

Updated 7 times since 2017 Last updated: Nov 1, 2018 Started: Feb 29, 2012 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No new participants enrolled. Protocol has been superseded

Other terminated trials from Baker Heart and Diabetes Institute

See all terminations from Baker Heart and Diabetes Institute

Other Hypertension trials with similar outcome

Browse all Hypertension trials

Listed as NCT01865240, this PHASE4 trial focuses on Hypertension and remains terminated or withdrawn. Sponsored by Baker Heart and Diabetes Institute, it has been updated 7 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE4
Dec 2018 — Nov 2020 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Jun 2018 — Dec 2018 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baker Heart and Diabetes Institute

Data source: Baker Heart and Diabetes Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia